Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulation For Tissue-Engineered Products Moves Forward In Europe

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers of some tissue-engineered products on the European market would have four years to comply with a new regulation working its way through the European Union legislative process
Advertisement

Related Content

European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied
Industry-Supported Tissue, Device Regs Clear European Union Council
Industry-Supported Tissue, Device Regs Clear European Union Council
New Proposal Would Bring EU Device Regs Up To Date With Current Practices
EU Proposal Gives Tissue Firms Only Two Years To Comply With New Regs
EU Proposal Gives Tissue Firms Only Two Years To Comply With New Regs
Advertisement
UsernamePublicRestriction

Register

MT024466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel